来源：市场资讯 （来源：吴说） 吴说获悉，SharpLink 宣布以约 4462 美元/枚的均价收购 56,533 枚 ETH（约 2.52 亿美元）。截至目前， SharpLink 持有 797,704 枚 ETH，价值约 37 亿美元。 ...

（来源：吴说） 吴说获悉，据 @EmberCN 监测，「12.5 万美元滚仓做多 ETH」鲸鱼仓位在昨夜今晨的市场下跌中被清 算，保证金仅剩 7 万美元。该鲸鱼上一波调整中从 4300 万美元盈利回吐到 686 万美元平仓；这次则直 接从昨天凌晨 919 万美元盈利到现在亏损 67 万美元。 来源：市场资讯 ...

Core Insights - A significant PEPE whale has increased its holdings after a 5-month period, indicating renewed confidence in the asset [1] - The whale withdrew 183.7 billion PEPE tokens from Binance, valued at approximately $2.035 million, at a price of $0.00001107 per token [1] - Despite a substantial unrealized loss of $7.25 million, the whale continues to hold 1.31 trillion PEPE tokens, with an average acquisition cost of $0.00001683 [1] - Since the initial investment in June 2024, the value of the whale's holdings has decreased by 69% [1]

Core Insights - SharpLink announced the acquisition of 143,593 ETH at an average price of approximately $4,648, totaling around $667 million [1] - The company's total ETH holdings have increased to 740,760 ETH [1] - SharpLink currently holds over $84 million in cash that has not yet been deployed [1] - Since the launch on June 2, the company has earned 1,388 ETH in staking rewards [1]

Core Viewpoint - Company plans to apply for a funding limit of up to 3 billion HKD for potential cryptocurrency purchases, aiming to enhance its "Global Enhanced Ethereum (ETH) Treasury" strategy and accelerate the tokenization ecosystem of medical innovation drug intellectual property [1] Group 1: Strategic Upgrade - The board previously approved a maximum of 880 million HKD for purchasing Ethereum as a strategic reserve, with the first batch of 5,190 ETH acquired for a total price of 149 million HKD at an average cost of approximately 28,798 HKD (3,661 USD) per unit [1] - The new announcement seeks to increase the funding limit to 3 billion HKD, positioning the company as a leader in Ethereum reserves among listed companies in Hong Kong and globally [1] - The company emphasizes that the acquisition plan will strictly adhere to the regulatory framework for virtual assets in Hong Kong, ensuring asset safety and liquidity through compliant channels [1] Group 2: Ecological Synergy - The cryptocurrency strategy is closely tied to the company's core business of tokenizing medical innovation drug assets (RWA), utilizing its self-developed Web3 exchange ivd.xyz to convert high-value medical assets into tradable digital certificates [2] - Ethereum serves as the underlying infrastructure, providing value anchoring for RWA and generating staking income to support the treasury's growth [2] - The company has implemented a "seven-layer downside protection mechanism" and a "three-tier income enhancement engine" to safeguard shareholder interests amid market volatility [2] Group 3: Market Response - Following the announcement of the first ETH purchase, the company's stock price surged over 91% within a month, with a market capitalization exceeding 15 billion HKD, making it a focal point in the Hong Kong medical sector [3] - Market analysis indicates that the company's dual-driven model of "crypto treasury + medical RWA" aligns with valuation logic seen in leading Ethereum companies in the US, while offering greater industrial synergy [3] - The company has established a strategic partnership with BGI Win-Win Fund to acquire quality innovative drug pipelines, further enhancing the asset base of the ivd.xyz exchange [3] Group 4: Compliance First - The company reiterated that all cryptocurrency transactions will be conducted exclusively on regulated platforms, seeking independent approval at the shareholder special meeting to ensure transparency [3] - If the 3 billion HKD application is approved, the authorization will be valid for 36 months, allowing the board to execute the purchase plan in phases based on market conditions [3] - As traditional medical companies explore digital transformation, the company's innovative model of "Ethereum treasury + medical RWA" opens new pathways for asset allocation and value reassessment in the industry [3]

Core Viewpoint - The company, Huajian Medical (01931), is seeking shareholder approval to authorize the board to purchase cryptocurrencies as part of its asset allocation strategy, specifically to strengthen its Ethereum (ETH) reserves and accelerate the development of the ivd.xyz exchange ecosystem [1] Group 1 - The board believes that purchasing and holding cryptocurrencies is a crucial step for the company's business layout and development [1] - The proposed authorization for cryptocurrency purchases will be valid for a period of 36 months from the date of approval at the special shareholder meeting [1] - The total amount allocated for cryptocurrency purchases will not exceed HKD 3 billion [1]

大举进军加密货币领域！由特朗普两个儿子支持的美国加密货币公司要在亚洲收购公司，以大量囤积加 密货币。 8月15日，据媒体报道，由特朗普两个儿子Eric Trump和Donald Trump Jr支持的美国加密货币矿企 American Bitcoin正在亚洲寻找收购目标，计划通过这些公司大量囤积加密货币。 据三名知情人士称，American Bitcoin计划收购一家日本上市公司，并可能同时收购一家香港公司。此 次收购计划旨在效仿Michael Saylor的MicroStrategy公司模式，通过亚洲平台扩大加密货币囤积规模。 该公司联合创始人兼首席战略官Eric Trump表示，公司的雄心是"打造世界上最强大、最高效的比特币 积累平台"。 此举可能为亚洲加密货币市场释放新的需求池，而且亚洲长期以来拥有对加密货币感兴趣的活跃散户交 易者群体。 效仿MicroStrategy模式进军亚洲 American Bitcoin已开始自建"战略性"比特币储备，并正在探索通过收购亚洲公司来扩大其加密货币囤积 规模。 这一策略效仿了MicroStrategy公司的做法，后者开创了通过上市公司囤积比特币的先河。MicroS ...

Saylor is, of course, right about all of this. Trump's support of crypto has been far beyond anything most could have imagined during the presidential election campaign. Congress recently passed the Genius Act, which will create a broad framework for stablecoins. The Clarity Act, which would create a broad framework for all cryptocurrencies, also has a good chance of passing Congress if the Senate approves the bill. This new legislation could help clear up regulatory uncertainty that has served as a roadblo ...

Group 1 - Fundamental Global has utilized the entire net proceeds of $200 million from a private placement to purchase Ethereum [1][2] - As of August 10, 2025, the company holds a total of 47,300 Ethereum, with an average purchase price of $4,228.40 [1][2]

Group 1: Cryptocurrency Market Surge - The cryptocurrency market experienced a significant surge, with Bitcoin reaching a peak of $122,370 per coin and Ethereum hitting $4,350, marking the highest levels since December 2021 [1][3] - Over the past 24 hours, more than 120,000 traders faced liquidation, with a total liquidation amount of approximately $426 million [3][4] - The rise in cryptocurrency prices is attributed to multiple factors, including institutional investments in Bitcoin and Ethereum spot ETFs, and increasing expectations of interest rate cuts by the Federal Reserve [1][5] Group 2: Institutional Interest and Investment Trends - Large investors have shown growing interest in cryptocurrencies, with nine Ethereum spot ETFs in the U.S. attracting over $6.7 billion in net inflows this year [7] - Companies focusing on accumulating cryptocurrencies have contributed to the price increases, with digital asset financial companies holding approximately $113 billion in Bitcoin reserves and around $13 billion in Ethereum [7] - Harvard Management Company has made significant investments in Bitcoin ETFs, acquiring 1.9 million shares of BlackRock's iShares Bitcoin ETF, valued at $116.7 million [8] Group 3: Market Dynamics and Future Outlook - Analysts suggest that the current market dynamics indicate a shift from Bitcoin to Ethereum, driven by strong inflows into spot ETFs and increasing corporate adoption of Ethereum [6][7] - The options market reflects bullish sentiment, with a put-call ratio of 0.39 for Ethereum, indicating a preference for bullish positions [7] - Experts predict that if Ethereum's weekly closing price exceeds $4,100, it may reach new historical highs within 1-2 weeks [6]